Literature DB >> 16809408

Skewed Th1 responses caused by excessive expression of Txk, a member of the Tec family of tyrosine kinases, in patients with Behcet's disease.

Noboru Suzuki1, Kazuhiko Nara, Tomoko Suzuki.   

Abstract

Behcet's disease (BD) is characterized by recurrent attacks of uveitis, oral aphtha, genital ulcers and skin lesions. The etiology and pathogenesis of BD are largely unknown. It has been reported that excessive Th1 cell function is involved in the pathogenesis of BD. Previously, we found that Txk, a member of the Tec family of tyrosine kinases, acts as a Th1 cell-specific transcription factor that is involved in the effector function of Th1 cells. Thus, we studied Th1 cytokine production and Txk expression of T-lymphocytes in patients with BD. Peripheral blood lymphocytes produced excessive Th1-associated cytokines including interferon-gamma (IFN-gamma) and interleukin (IL)-12 in patients with BD. Circulating CD3+ and purified CD4+ T cells expressed excessive Txk protein. The extent of IFN-gamma production by the lymphocytes correlated with the expression of Txk protein in the immunoblotting analysis. The majority of cells infiltrating into the skin lesions of patients with BD expressed IFN-gamma. IL-12 and IL-18 were found in the mononuclear cell aggregates in the skin and intestinal lesions of those with BD. Lymphocytes accumulating in the skin and intestinal lesions expressed higher levels of Txk as compared with other Th2-associated diseases. IFN-gamma, IL-18 and IL-12 detected in skin lesions may induce preferential development of Th1 cells in patients with BD. Collectively, Th1 cells expressing Txk and Th1-associated cytokines may play a critical role in the development of skin and intestinal lesions in patients with BD. This review may serve as a reminder of the importance of excessive Th1 cell function in the pathogenesis of BD and may contribute to the discovery of new molecular targets for the development of a specific therapeutic strategy for BD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16809408      PMCID: PMC1483892          DOI: 10.3121/cmr.4.2.147

Source DB:  PubMed          Journal:  Clin Med Res        ISSN: 1539-4182


  48 in total

Review 1.  T cell chemokine receptor expression in human Th1- and Th2-associated diseases.

Authors:  J D Campbell; K T HayGlass
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2000       Impact factor: 4.291

Review 2.  Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51.

Authors:  H Direskeneli
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

3.  Evidence of autophosphorylation in Txk: Y91 is an autophosphorylation site.

Authors:  Jun-Ichi Kashiwakura; Noboru Suzuki; Mitsuhiro Takeno; Saotomo Itoh; Teruaki Oku; Tsuyoshi Sakane; Shizuo Nakajin; Satoshi Toyoshima
Journal:  Biol Pharm Bull       Date:  2002-06       Impact factor: 2.233

Review 4.  Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling.

Authors:  Jessica M Lindvall; K Emelie M Blomberg; Jouni Väliaho; Leonardo Vargas; Juhana E Heinonen; Anna Berglöf; Abdalla J Mohamed; Beston F Nore; Mauno Vihinen; C I Edvard Smith
Journal:  Immunol Rev       Date:  2005-02       Impact factor: 12.988

5.  Clinical and immunological effects of azithromycin in Behçet's disease.

Authors:  G Mumcu; T Ergun; Y Elbir; E Eksioglu-Demiralp; S Yavuz; T Atalay; H Direskeneli
Journal:  J Oral Pathol Med       Date:  2005-01       Impact factor: 4.253

6.  T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behçet's disease.

Authors:  H Direskeneli; E Ekşioglu-Demiralp; S Yavuz; T Ergun; T Shinnick; T Lehner; T Akoglu
Journal:  J Rheumatol       Date:  2000-03       Impact factor: 4.666

7.  Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease.

Authors:  N Sugi-Ikai; M Nakazawa; S Nakamura; S Ohno; M Minami
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-05       Impact factor: 4.799

8.  Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity.

Authors:  B Turan; H Gallati; H Erdi; A Gürler; B A Michel; P M Villiger
Journal:  J Rheumatol       Date:  1997-01       Impact factor: 4.666

9.  Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12.

Authors:  M A Frassanito; R Dammacco; P Cafforio; F Dammacco
Journal:  Arthritis Rheum       Date:  1999-09

10.  IL-18 mRNA expression and IFN-gamma induction in bronchoalveolar lavage from Behçet's disease.

Authors:  A Hamzaoui; H Ghraïri; J Ammar; S Zekri; F Guemira; K Hamzaoui
Journal:  Clin Exp Rheumatol       Date:  2003 Jul-Aug       Impact factor: 4.473

View more
  15 in total

Review 1.  Tec family kinases Itk and Rlk / Txk in T lymphocytes: cross-regulation of cytokine production and T-cell fates.

Authors:  Julio Gomez-Rodriguez; Zachary J Kraus; Pamela L Schwartzberg
Journal:  FEBS J       Date:  2011-03-29       Impact factor: 5.542

Review 2.  Behçet syndrome: from pathogenesis to novel therapies.

Authors:  Gianluigi Mazzoccoli; Angela Matarangolo; Rosa Rubino; Michele Inglese; Angelo De Cata
Journal:  Clin Exp Med       Date:  2014-12-02       Impact factor: 3.984

3.  Soluble levels of osteopontin in patients with Behcet's disease: association with disease activity and vascular involvement.

Authors:  Iman H Bassyouni; Mohammed M El-Wakd; Rasha H Bassyouni
Journal:  J Clin Immunol       Date:  2012-10-25       Impact factor: 8.317

4.  Selective expression rather than specific function of Txk and Itk regulate Th1 and Th2 responses.

Authors:  Nisebita Sahu; Ana M Venegas; Dragana Jankovic; Wayne Mitzner; Julio Gomez-Rodriguez; Jennifer L Cannons; Connie Sommers; Paul Love; Alan Sher; Pamela L Schwartzberg; Avery August
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

5.  Expression of Th-17 and RORγt mRNA in Behçet's Disease.

Authors:  Kamel Hamzaoui; Eya Bouali; Imed Ghorbel; Monia Khanfir; Habib Houman; Agnes Hamzaoui
Journal:  Med Sci Monit       Date:  2011-04

6.  Gene-expression profiling of calves 6 and 9 months after inoculation with Mycobacterium avium subspecies paratuberculosis.

Authors:  Joel David; Herman W Barkema; Le Luo Guan; Jeroen De Buck
Journal:  Vet Res       Date:  2014-10-02       Impact factor: 3.683

7.  Do synovial biopsies help to support evidence for involvement of innate immunity in the immunopathology of Behçet's disease?

Authors:  Jan A M van Laar; Jasper H Kappen; Paul L A van Daele; P Martin van Hagen
Journal:  Arthritis Res Ther       Date:  2009-04-30       Impact factor: 5.156

8.  Distinct synovial immunopathology in Behçet disease and psoriatic arthritis.

Authors:  Juan D Cañete; Raquel Celis; Troy Noordenbos; Conchita Moll; Jose A Gómez-Puerta; Pilar Pizcueta; Antonio Palacin; Paul P Tak; Raimon Sanmartí; Dominique Baeten
Journal:  Arthritis Res Ther       Date:  2009-02-06       Impact factor: 5.156

9.  Transcriptional regulation of kinases downstream of the T cell receptor: another immunomodulatory mechanism of glucocorticoids.

Authors:  Maria Grazia Petrillo; Katia Fettucciari; Paolo Montuschi; Simona Ronchetti; Luigi Cari; Graziella Migliorati; Emanuela Mazzon; Oxana Bereshchenko; Stefano Bruscoli; Giuseppe Nocentini; Carlo Riccardi
Journal:  BMC Pharmacol Toxicol       Date:  2014-07-03       Impact factor: 2.483

10.  Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia.

Authors:  Christopher A Eide; Stephen E Kurtz; Andy Kaempf; Nicola Long; Anupriya Agarwal; Cristina E Tognon; Motomi Mori; Brian J Druker; Bill H Chang; Alexey V Danilov; Jeffrey W Tyner
Journal:  Leukemia       Date:  2020-02-24       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.